Published in
Taylor and Francis Group, OncoImmunology, p. e1457596
DOI: 10.1080/2162402x.2018.1457596
Links
Tools
Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors
Journal article published in 2018 by
S. Feola,
C. Capasso,
M. Fusciello 
,
B. Martins,
S. Tähtinen,
M. Medeot,
S. Carpi,
F. Frascaro,
E. Ylosmäki,
K. Peltonen ,
L. Pastore,
V. Cerullo
,
B. Martins,
S. Tähtinen,
M. Medeot,
S. Carpi,
F. Frascaro,
E. Ylosmäki,
K. Peltonen ,
L. Pastore,
V. Cerullo
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 